Showing results (2001-2010 of 2,122) with videos related to

Sort By:
Pageof 213
Neuron|November 29, 2024
Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's diseasePourya Naderi Yeganeh, Sang Su Kwak, Mehdi Jorfi, et al.
Clinical Cardiology|July 1, 2010
Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR) studyJong-Seon Park, Young-Jo Kim, Dong-Gu Shin, et al.
Experimental & Molecular Medicine|June 22, 2011
5-(4-Hydroxy-2,3,5-trimethylbenzylidene) thiazolidine-2,4-dione attenuates atherosclerosis possibly by reducing monocyte recruitment to the lesionJae-Hoon Choi, Jong-Gil Park, Hyung Jun Jeon, et al.
Journal of Molecular Neuroscience : MN|June 26, 2016
Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse HippocampusJoon Ha Park, Hyun Young Choi, Jeong-Hwi Cho, et al.
Circulation Research|November 30, 2022
TXNIP Suppresses the Osteochondrogenic Switch of Vascular Smooth Muscle Cells in AtherosclerosisSang-Ho Woo, Dongsoo Kyung, Seung Hyun Lee, et al.
Journal of Cardiology|October 11, 2016
Relationship between time to treatment and mortality among patients undergoing primary percutaneous coronary intervention according to Korea Acute Myocardial Infarction RegistryHyun Kuk Kim, Myung Ho Jeong, Youngkeun Ahn, et al.
Free Radical Biology & Medicine|December 9, 2014
Ischemic preconditioning protects hippocampal pyramidal neurons from transient ischemic injury via the attenuation of oxidative damage through upregulating heme oxygenase-1Jae-Chul Lee, In Hye Kim, Joon Ha Park, et al.
Drug Design, Development and Therapy|August 31, 2016
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)Jin-Sun Park, Joon-Han Shin, Taek-Jong Hong, et al.
Molecular Therapy. Nucleic Acids|August 6, 2024
Discovery of novel disease-causing mutation in SSBP1 and its correction using adenine base editor to improve mitochondrial functionJu Hyuen Cha, Seok-Hoon Lee, Yejin Yun, et al.
Plos One|September 30, 2011
Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietinSe Jin Im, Sang In Yang, Se Hwan Yang, et al.
Pageof 213